39 results found.

Autism Spectrum Disorders Clinical Trial using Vasopressin; Placebo

Stanford University - Recruiting 6 years to 12 years.
- Randomized Placebo-controlled Trial of Vasopressin Treatment for Social Deficits in Children With Autism.
Vasopressin; Placebo

Autism Spectrum Disorders Clinical Trial

Children's Hospital Medical Center, Cincinnati - Recruiting 3 years to 25 years.
- Extracellular Signal-Related Kinase Biomarker Development in Autism.

Autistic Disorder Clinical Trial using Acamprosate; Placebo

Children's Hospital Medical Center, Cincinnati - Recruiting 5 years to 17 years.
- Double-Blind Placebo-Controlled Study of Acamprosate in Autism.
Acamprosate; Placebo

Autism Spectrum Disorders Clinical Trial using Riluzole; placebo

Children's Hospital Medical Center, Cincinnati - Recruiting 12 years to 26 years.
- A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders.
Riluzole; placebo

Autism, Language Acquisition, Language Development, or Toddlers Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 10 Months to 20 Months.
- Markers of Autism Spectrum Disorders in At-Risk Toddlers: A Pilot Study.

Autism Spectrum Disorder Clinical Trial using MRT-Active; MRT-SHAM

Newport Brain Research Laboratory - Recruiting 4 years to 12 years.
- A Randomized Double-Blind Sham-Controlled Trial To Evaluate The Treatment Efficacy of Magnetic Resonant Therapy in Autistic Disorder.
MRT-Active; MRT-SHAM

Autism Spectrum Disorders Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A to 20 years.
- Screening Protocol for Studies of the Pediatrics and Developmental Neuroscience Branch.

Autism Spectrum Disorder Clinical Trial

St. Louis University - Recruiting 6 Months to 36 Months.
- Early Detection of Autism Spectrum Disorder in Children.

Autism Spectrum Disorders Clinical Trial using Provider Education Model (PEM)

Hugo W. Moser Research Institute at Kennedy Krieger, Inc. - Recruiting 24 Months to 42 Months.
- Improving Part C Services and Outcomes for Under-resourced Children With ASD.
Provider Education Model (PEM)

Attention Deficit Disorder With Hyperactivity, Attention Deficit Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 4 years to 8 years.
- Near Infra-Red Spectroscopy (NIRS) in Neurodevelopmental Disorders and Typically Developing Children.

Autism Spectrum Disorders, Brain Disease, Autism, or Healthy Volu Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 45 years.
- Neuroimmune Activation in Austism: Imaging Translocator Protein Using Positron Emission Tomography (PET).

Autism Spectrum Disorder, Obsessive Compulsive Disorder, Pediatri Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Diagnosis and Treatment of Childhood-onset Behavioral Disorders, Neuropsychiatric Disorders and Neurodevelopmental Disorders.

Autism Spectrum Disorders Clinical Trial using Donepezil; Placebo

National Institutes of Health Clinical Center (CC) - Recruiting 24 Months to 50 Months.
- A Randomized Controlled Trial of Donepezil for REM Enhancement and Behavioral Change in Autism.
Donepezil; Placebo

Autism Spectrum Disorders Clinical Trial using Sham OMM; Osteopathic Manual Medicine (Body Therapy)

New York Institute of Technology - Recruiting 3 years to 8 years.
- Osteopathic Manual Medicine Treatment in Autism, A Pilot Study.
Sham OMM; Osteopathic Manual Medicine (Body Therapy)

Autistic Disorder, Seizures, or Irritability Clinical Trial using N-Acetyl Cysteine (NAC)

Nationwide Children's Hospital - Recruiting 6 years to 21 years.
- Pilot Study of N-acetyl Cysteine for Refractory Generalized Epilepsy in Children With Autism.
N-Acetyl Cysteine (NAC)

Autism Clinical Trial using Lurasidone 20 mg daily; Lurasidone; Placebo 20 or 60 mg

Sunovion - Recruiting 6 years to 17 years.
- A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder.
Lurasidone 20 mg daily; Lurasidone; Placebo 20 or 60 mg

Autism Clinical Trial

SynapDx - Recruiting 18 Months to 60 Months.
- SynapDx Autism Spectrum Disorder Gene Expression Analysis Study.

Autism Spectrum Disorder (ASD) Clinical Trial using Pivotal Response Treatment Package (PRT-P)

Stanford University - Recruiting 2 years to 5 years.
- Pivotal Response Treatment Package for Young Children With Autism.
Pivotal Response Treatment Package (PRT-P)

Autistic Disorder, or Developmental Disabilities Clinical Trial using Pivotal Response Training (PRT); PACE Therapy; PACE and PRT Hybrid

Stanford University - Recruiting 18 Months to 17 years.
- .
Pivotal Response Training (PRT); PACE Therapy; PACE and PRT Hybrid

Autism Spectrum Disorder Clinical Trial using ISC+PRT Intervention

Hugo W. Moser Research Institute at Kennedy Krieger, Inc. - Recruiting 3 years to 6 years.
- Development of a Social and Communication Intervention for Preschoolers With Autism.
ISC+PRT Intervention

Autism Spectrum Disorders, Autism, Asperger's Syndrome, Pervasive Clinical Trial using Personalized Cognitive-behavioral therapy; Standard Practice Cognitive-behavioral therapy

University of South Florida - Recruiting 8 years to 13 years.
- 2/3 Treatment of Anxiety in Autism Spectrum Disorder.
Personalized Cognitive-behavioral therapy; Standard Practice Cognitive-behavioral therapy

Autism Spectrum Disorder Clinical Trial using Social Enhancement Intervention; Parent Education

Hugo W. Moser Research Institute at Kennedy Krieger, Inc. - Recruiting 24 Months to 42 Months.
- Effects of Self-Generated Experiences on Social Cognitive Development in Young Children With Autism.
Social Enhancement Intervention; Parent Education

Autism, Asperger's Syndrome, Pervasive Developmental Disorder Not Clinical Trial using Cognitive Behavioral Therapy; Treatment as usual

University of South Florida - Recruiting 6 years to 12 years.
- Exposure-Focused Family-Based CBT for Youth With ASD and Comorbid Anxiety.
Cognitive Behavioral Therapy; Treatment as usual

Autism Clinical Trial using Spinal Manipulative Therapy (SMT); SMT and Neuromuscular Reeducation

Southern California University of Health Sciences - Recruiting 5 years to 15 years.
- The Effects of Spinal Manipulative Therapy and Neuromuscular Reeducation on the Presentation of Autistic Symptoms in Children.
Spinal Manipulative Therapy (SMT); SMT and Neuromuscular Reeducation

Autism, Enuresis, or Incontinence Clinical Trial using Wireless Moisture Pager (WMP)

University of Rochester - Recruiting 3 years to 6 years.
- Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism.
Wireless Moisture Pager (WMP)

Autism Clinical Trial using Trichuris Suis Ova

Montefiore Medical Center - Recruiting 18 years to 35 years.
- Trichuris Suis Ova in Autism Spectrum Disorders.
Trichuris Suis Ova

Autism Spectrum Disorder Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Exome Sequencing in Autistic Spectrum Disorder Patients With Altered Cholesterol Homeostasis.

Autism Clinical Trial using Nuedexta

Sutter Health - Recruiting 18 years to 60 years.
- Nuedexta for Neurobehavioral Symptoms of Adults With Autism Spectrum Disorder.
Nuedexta

Tuberous Sclerosis Complex Clinical Trial

Children's Hospital Boston - Recruiting 3 Months to 9 Months.
- Longitudinal Study to Identify Early Biomarkers of Autism Spectrum Disorder (ASD) in Infants With Tuberous Sclerosis Complex (TSC).

Autism Clinical Trial using CM-AT

Curemark - Recruiting 9 years to 12 years.
- A Phase III Open Label Extension Study of CM-AT in Children With Autism.
CM-AT

Child Development Disorders, Pervasive Clinical Trial using Mifne Approach to PDD; Treatment as usual

Rabin Medical Center - Recruiting 2 years to 5 years.
- .
Mifne Approach to PDD; Treatment as usual

Autism Spectrum Disorders, or Schizophrenia Clinical Trial using Neuropsychological evaluation

University Hospital, Strasbourg, France - Recruiting 7 years to 55 years.
- Visual Exploration and Attention : Studies in Patients With Schizophrenia and Autism Spectrum Disorders.
Neuropsychological evaluation

Tactile Defensiveness, or Autism Spectrum Disorder Clinical Trial using baclofen, intrathecal

University of Missouri-Columbia - Recruiting 10 years to 65 years.
- Open Label Treatment of Severe Tactile Defensiveness With Intrathecal Baclofen.
baclofen, intrathecal

Sleep Problems Clinical Trial using Melatonin; Placebo

Baylor College of Medicine - Recruiting 4 years to 9 years.
- Treatment of Sleep Problems in Children With Autism Spectrum Disorder With Melatonin: A Double-blind, Placebo-controlled Study..
Melatonin; Placebo

Autism, or ASD Clinical Trial using Syntocinon

Bartz, Jennifer, Ph.D. - Recruiting 18 years to 45 years.
- The Effects of Oxytocin on Complex Social Cognition in Autism Spectrum Disorders.
Syntocinon

Asperger Syndrome, or Autism Clinical Trial using questionnaires

Groupe Francais d'Epidemiologie Psychiatrique - Recruiting 12 years to 18 years.
- Evaluation of the French Version of Screening Questionnaires for Autism and Asperger Syndrome : Autism Spectrum Quotient (AQ) Empathy Quotient (EQ) and Systemizing Quotient (SQ).
questionnaires